Studies raise concerns that taking anemia drugs after chemo may be harmful

02/27/2007 |

Anemia drugs sold by Amgen, Johnson & Johnson and Roche could be harming some cancer patients instead of helping them, new studies conclude. The drugs are used to treat anemia that results from chemotherapy, but the studies suggest use of those drugs for that purpose may make the cancer worse. Amgen said its anemia drug was safe and effective when used as intended.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health